Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04616651 · ClinicalTrials.gov registry record · NA
Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT04616651 is a NA study that was terminated before completion, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 18 participants.
The verdict
NCT04616651, a NA study, was terminated before completion, sponsored by University of Michigan Rogel Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study is designed to study the feasibility and acceptability of the Open to Options (O2O) Chatbot prototype. The O2O program is an existing patient support program with content currently delivered via in-person counseling with a trained mental health professional or via an existing web-based program (Let's Talk Treatment Options).The Chatbot is an automated, menu-based agent being developed in this study to extend the reach and accessibility of the O2O program via the Chatbot's "virtual coaching".
Interventions
- BEHAVIORAL Online Survey
- BEHAVIORAL Chatbot prototype
- BEHAVIORAL Open to Options (O2O) Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-03-25 |
| Est. Completion | 2021-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04616651
The ClinicalTrials.gov registry entry for NCT04616651 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Online Survey is the first listed.
NCT04616651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04616651 about?
NCT04616651 is a clinical study titled "Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program". This study is designed to study the feasibility and acceptability of the Open to Options (O2O) Chatbot prototype. The O2O program is an existing patient support program with content currently delivered via in-person counseling with a trained mental health professional or via an existing web-based pr...
What is the current status of trial NCT04616651?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2021-03-25. Estimated completion is 2021-08-10.
What interventions are being tested in trial NCT04616651?
The interventions under investigation include: Online Survey (BEHAVIORAL), Chatbot prototype (BEHAVIORAL), Open to Options (O2O) Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04616651?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.